These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38543864)

  • 1. Calcium Chloride Treatment Enhances Antigen Production in Foot-and-Mouth Disease Vaccines for Serotypes SAT1 and SAT3.
    Kim D; Park SY; Lee G; Kim ES; Jin JS; Kim JY; Lee S; Park JH; Ko YJ
    Vaccines (Basel); 2024 Feb; 12(3):. PubMed ID: 38543864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs.
    Jo HE; You SH; Choi JH; Ko MK; Shin SH; Song J; Jo H; Lee MJ; Kim SM; Kim B; Park JH
    Virol J; 2019 Dec; 16(1):156. PubMed ID: 31842907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and Epitope Mapping Potential of Single-Chain Antibody Fragments Against Foot-and-Mouth Disease Virus Serotypes A, SAT1, and SAT3.
    Chitray M; Opperman PA; Rotherham L; Fehrsen J; van Wyngaardt W; Frischmuth J; Rieder E; Maree FF
    Front Vet Sci; 2020; 7():475. PubMed ID: 32851044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherent biophysical stability of foot-and-mouth disease SAT1, SAT2 and SAT3 viruses.
    Scott KA; Maake L; Botha E; Theron J; Maree FF
    Virus Res; 2019 Apr; 264():45-55. PubMed ID: 30807778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of reverse-transcriptase, real-time PCR assays to distinguish the Southern African Territories (SAT) serotypes 1 and 3 and topotype VII of SAT2 of Foot-and-Mouth Disease Virus.
    Chestley T; Sroga P; Nebroski M; Hole K; Ularamu H; Lung O; Nfon C
    Front Vet Sci; 2022; 9():977761. PubMed ID: 36204292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a foot-and-mouth disease vaccine against a heterologous SAT1 virus challenge in goats.
    Lazarus DD; Peta F; Blight D; Van Heerden J; Mutowembwa PB; Heath L; Blignaut B; Opperman PA; Fosgate GT
    Vaccine; 2020 May; 38(24):4006-4015. PubMed ID: 32312581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a Foot-and-Mouth Disease Vaccine Antigen Using Suspension-Adapted BHK-21 Cells in a Bioreactor.
    Park S; Kim JY; Ryu KH; Kim AY; Kim J; Ko YJ; Lee EG
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34068378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted FMD Vaccines for Eastern Africa: The AgResults Foot and Mouth Disease Vaccine Challenge Project.
    Hammond JM; Maulidi B; Henning N
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the optimal medium and application strategy for foot-and-mouth disease vaccine antigen production.
    Kim AY; Kim H; Park SY; Park SH; Lee JM; Kim JS; Park JW; Park CK; Park JH; Ko YJ
    J Appl Microbiol; 2021 Sep; 131(3):1113-1122. PubMed ID: 33544957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa.
    Jackson B; Harvey Y; Perez-Martin E; Wilsden G; Juleff N; Charleston B; Seago J
    Vaccine; 2021 Aug; 39(35):5015-5024. PubMed ID: 34303562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of honey bee venom effect on the immunogenicity of foot-and-mouth disease vaccine in sheep.
    Eweis ARF; Hassan KM; Shoman SAH; Taha HA; Mohamed EE
    Open Vet J; 2022; 12(6):919-928. PubMed ID: 36650860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of foot-and-mouth disease in Ethiopia: epidemiological aspects, economic implications, and control strategies.
    Zewdie G; Akalu M; Tolossa W; Belay H; Deresse G; Zekarias M; Tesfaye Y
    Virol J; 2023 Dec; 20(1):299. PubMed ID: 38102688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological analysis, serological prevalence and genotypic analysis of foot-and-mouth disease in Nigeria 2008-2009.
    Ehizibolo DO; Perez AM; Carrillo C; Pauszek S; AlKhamis M; Ajogi I; Umoh JU; Kazeem HM; Ehizibolo PO; Fabian A; Berninger M; Moran K; Rodriguez LL; Metwally SA
    Transbound Emerg Dis; 2014 Dec; 61(6):500-10. PubMed ID: 23347819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Five-Year Retrospective Study of Foot-and-Mouth Disease Outbreaks in Southern Africa, 2014 to 2018.
    Fana EM; Mpoloka SW; Leteane M; Seoke L; Masoba K; Mokopasetso M; Rapharing A; Kabelo T; Made P; Hyera J
    Vet Med Int; 2021; 2021():7438809. PubMed ID: 35003620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for performing antigenic vaccine matching for foot-and-mouth disease in absence of the homologous virus.
    Sirdar MM; Fosgate GT; Blignaut B; Gummow B; Shileyi B; Lazarus DD; Mutowembwa P; van der Merwe D; Heath L
    Vaccine; 2019 Aug; 37(35):5025-5034. PubMed ID: 31296377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotype Diversity of Foot-and-Mouth-Disease Virus in Livestock without History of Vaccination in the Far North Region of Cameroon.
    Ludi A; Ahmed Z; Pomeroy LW; Pauszek SJ; Smoliga GR; Moritz M; Dickmu S; Abdoulkadiri S; Arzt J; Garabed R; Rodriguez LL
    Transbound Emerg Dis; 2016 Feb; 63(1):e27-38. PubMed ID: 24735162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of laboratory tests for SAT serotypes of foot-and-mouth disease virus with specimens collected from convalescent cattle in Zimbabwe.
    Sammin DJ; Paton DJ; Parida S; Ferris NP; Hutchings GH; Reid SM; Shaw AE; Holmes C; Gibson D; Corteyn M; Knowles NJ; Valarcher JF; Hamblin PA; Fleming L; Gwaze G; Sumption KJ
    Vet Rec; 2007 May; 160(19):647-54. PubMed ID: 17496271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Modulatory Potential of Anti-idiotype Antibodies as a Surrogate of Foot-and-Mouth Disease Virus Antigen.
    Naveed A; Rahman SU; Arshad MI; Aslam B
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Improved αvβ6-Receptor-Expressing Suspension Cell Line for Foot-and-Mouth Disease Vaccine Production.
    Harvey Y; Jackson B; Carr BV; Childs K; Moffat K; Freimanis G; Tennakoon C; Juleff N; Seago J
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.